In terms of market performance, Mersana Therapeutics Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $6.28 on 03/11/24, while the lowest value was $0.49 on 01/23/25.
52-week price history of MRSN Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Mersana Therapeutics Inc’s current trading price is -89.76% away from its 52-week high, while its distance from the 52-week low is 30.94%. The stock’s price range for this period has remained between $0.49 and $6.28. The Healthcare sector company’s shares managed to surpass a trading volume of around 18.6 million for the day, which was noticeably higher compared to the shares’ average daily volume of 3.55 million over the last three months.
Financial Performance and Market Capitalization
Mersana Therapeutics Inc (MRSN) has experienced a quarterly decline of -68.62% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 79.47M and boasts a workforce of 123 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.8301, with a change in price of -0.8767. Similarly, Mersana Therapeutics Inc recorded 2,703,290 in trading volume during the last 100 days, posting a change of -57.68%.
MRSN Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MRSN stands at 30.00. Similarly, the long-term debt-to-equity ratio is also 15.51.
MRSN Stock Stochastic Average
As of today, the raw stochastic average of Mersana Therapeutics Inc over the past 50 days is 6.50%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 13.29%. Additionally, the Stochastic %K and %D values for the company were 5.53% and 2.83%, respectively, over the past 20 days.
MRSN Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price loss of -55.01% this year. Over the last six months, there has been a stronger performance of -69.94%. The price of MRSN leaped by -59.79% during the last 30 days period. For the last 5-days stocks have improved 4.70%.
